Navigation Links
Tyber Medical Closes Private Placement Funding Round

MORRISTOWN, N.J., Nov. 25, 2013 /PRNewswire/ -- Tyber Medical, LLC, a privately held medical device company focused on developing innovative spine and orthopaedic devices for private label opportunities and first to market with titanium plasma spray coated direct lateral implants for the spine, announces the closing of a successful initial funding round.

(Photo: )

Tyber Medical, LLC, a market leader in titanium plasma spray coated interbody fusion devices, today announced it closed a private equity funding round for an undisclosed amount. The company will use the capital to acquire resources necessary to accelerate the market penetration of the TyPEEK interbody product portfolio, and develop additional products for the spine and orthopedic markets.

TyPEEK, proprietary titanium plasma sprayed interbody fusion devices, are specifically designed for situations where PEEK alone may not provide the best setting for fusion. TyPEEK is designed to offer the benefits of bone - titanium osseointegration along with the modulus and post op imaging characteristics of PEEK.

"This initial round of fundraising allows us to accelerate our domestic and international sales strategy, with continued development of future trauma and extremity products to complement our customers' existing product lines," commented Jeff Tyber, CEO and President of Tyber Medical.

About Tyber Medical:

Tyber Medical, LLC, Morristown, New Jersey, a private labeler Original Equipment Manufacturer (OEM), is creating new pathways to regulatory approved implants and instruments for orthopedic companies, large distributors, and hospital organizations. Tyber Medical designs and develops full class II orthopedic systems; verifies and validates those systems using a QSR and ISO 13485 certified quality system; and pursues and maintains both US (FDA 510k) and OUS (CE Mark) regulatory approvals. Current products include spinal interbody spacers featuring both standard sterile and non-sterile PEEK and TyPEEK™, a proprietary titanium plasma sprayed PEEK. For more information, please visit

Tyber Medical Interbody systems are made with PEEK-OPTIMA® from Invibio® Biomaterial Solutions.

Steve Zeiger
89 Headquarters Plaza North, #1464
Morristown, New Jersey 07960
(866) 761-0933

SOURCE Tyber Medical, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tyber Medical Elects Arthur Alfaro As Board Member
2. Tyber Medical Adds Surgeon Advisors
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Essential Medical Dismisses Patent Case against Masimo and Cercacor
11. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):